Literature DB >> 3967172

Morphologic characteristics of benign and malignant adrenocortical tumors.

H van Slooten, A Schaberg, D Smeenk, A J Moolenaar.   

Abstract

Differentiation between benign and malignant tumors of the adrenal cortex was studied by means of seven histologic parameters. Each separate criterion was significantly different in two groups, one consisting of patients without metastases within 10 years after operation and one of patients with metastatic tumors. Discrimination on the basis of single parameters in individual patients, however, was of little value. When a histologic index was calculated using the same parameters but after "weighing," a much better discrimination was obtained. The histologic index and, to a lesser degree, the mitotic activity seems to be related to the survival time of the patients with adrenal cortical carcinoma. The authors conclude that the calculation of a histologic index based on a summation of different parameters makes it possible to differentiate between malignant and benign adrenal cortical tumors. As single parameters, tumor weight and mitotic activity have the highest discriminating value.

Entities:  

Mesh:

Year:  1985        PMID: 3967172     DOI: 10.1002/1097-0142(19850215)55:4<766::aid-cncr2820550414>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  63 in total

1.  Monoclonal Antibodies Recognizing Normal and Neoplastic Human Adrenal Cortex.

Authors:  Carin Backlin; Claes Juhlin; Lars Grimelius; Kristina Wiberg; Per Heilman; Goran Akerstrom; Jonas Rastad
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 2.  Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.

Authors:  Adrienne Carruth Griffin; Rachel Kelz; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 3.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  [Neuroendocrine tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

5.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

6.  Adrenal cortical diseases: international case conference.

Authors:  Hironobu Sasano; Takashi Suzuki; Junji Irie; Kioko Kawai; Motohiko Aiba; Anne Marie McNicol; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 7.  [Adrenocortical tumours].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-06       Impact factor: 1.011

8.  [Diagnostic pitfalls with Cushing's syndrome].

Authors:  W Hunger-Battefeld; M Gajda; A Hansch; A Mandecka; U A Müller; G Wolf
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

9.  Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.

Authors:  J Waldmann; G Feldmann; E P Slater; P Langer; M Buchholz; A Ramaswamy; W Saeger; M Rothmund; V Fendrich
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

10.  Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature.

Authors:  Pinelopi Argyriou; Charalambos Zisis; Nektarios Alevizopoulos; Emmanuel M Kefaloyannis; Constantine Gennatas; Constantina D Petraki
Journal:  World J Surg Oncol       Date:  2008-12-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.